Pravastatin is a hydrophilic HMG-CoA reductase inhibitor used to lower cholesterol by reducing hepatic cholesterol synthesis, thereby decreasing low-density lipoprotein (LDL) levels. It is clinically important for preventing cardiovascular events in patients with hyperlipidaemia or established atherosclerotic disease. Unlike some other statins, pravastatin has a lower risk of drug interactions and muscle toxicity, making it preferable in patients on multiple medications.
Please confirm you want to block this member.
You will no longer be able to:
Please allow a few minutes for this process to complete.